What intravenous medications and dosing schedule are recommended for an adult with moderate to severe alcohol withdrawal?

IV Medications for Moderate to Severe Alcohol Withdrawal

For moderate to severe alcohol withdrawal syndrome, intravenous benzodiazepines—specifically lorazepam 1-4 mg IV every 4-8 hours or diazepam 5-10 mg IV every 6-8 hours—are the gold standard first-line treatment, with lorazepam preferred in patients with liver dysfunction, advanced age, or respiratory compromise. 1, 2, 1

Primary IV Benzodiazepine Regimens

Lorazepam (Preferred in Most Hospitalized Patients)

• Dosing: 1-4 mg IV/IM every 4-8 hours 1
• Starting dose for severe AWS: 6-12 mg/day total, divided into multiple doses 1
• Advantages: Safer in elderly patients, liver failure, respiratory failure, obesity, and other serious medical comorbidities 1
• Rationale: Intermediate-acting with predictable metabolism independent of hepatic function

Diazepam (Alternative)

• Dosing: 5-10 mg IV/IM every 6-8 hours 1
• Advantages: Long-acting, provides better protection against seizures and delirium tremens 2
• Caution: Accumulates in hepatic dysfunction; less predictable in critically ill patients

Dosing Strategy

Use symptom-triggered regimens rather than fixed-dose schedules to prevent drug accumulation 2. However, in patients too ill to participate in symptom scoring or with medical complexity obscuring withdrawal assessment, fixed-dose protocols with close monitoring are appropriate 3.

Essential Adjunctive IV Therapy

Thiamine (Critical—Always Administer)

• Dosing: 100-300 mg/day IV for prevention of Wernicke encephalopathy 1
• For established Wernicke encephalopathy: 100-500 mg/day IV 1
• Critical timing: Give thiamine BEFORE any IV glucose-containing fluids, as glucose administration can precipitate acute thiamine deficiency 1
• Duration: Maintain for 2-3 months following resolution of withdrawal symptoms 1

Supportive IV Fluids and Electrolytes

• Correct dehydration, electrolyte imbalances (especially magnesium), and monitor for renal failure 1
• Frequent vital sign monitoring is essential 1

Adjunctive IV Medications for Refractory Cases

Phenobarbital (For Benzodiazepine-Resistant Severe AWS)

Front-loaded phenobarbital (10-20 mg/kg IV) is increasingly used for benzodiazepine-refractory severe alcohol withdrawal and significantly reduces mechanical ventilation rates compared to low-intermittent dosing. 4

• Front-loading protocol: 10-20 mg/kg IV infusion over 30 minutes 5, 4
  • The 20 mg/kg dose may reduce benzodiazepine requirements without increasing intubation risk 5
  • Front-loaded dosing reduces mechanical ventilation incidence (28% vs 63% with low-intermittent dosing) 4
• Low-intermittent protocol (older approach): 260 mg IV push × 1, then 130 mg IV every 15-30 minutes to light sedation 6, 4
• Serum level guidance: Each mg/kg raises serum phenobarbital by approximately 1.65 mcg/mL 6
• Use when: Patients remain symptomatic despite adequate benzodiazepine dosing, before ICU transfer if possible 7

Haloperidol (For Agitation/Psychosis Only)

• Dosing: 2-5 mg IM (or 0.5-5 mg PO/IM every 8-12 hours) 1
• Use carefully as adjunctive therapy ONLY for agitation or psychotic symptoms (hallucinations) not controlled by benzodiazepines 1
• Not for primary AWS treatment—does not prevent seizures or delirium tremens

Dexmedetomidine (Emerging Alternative)

• Reduces intubation rates (13.3% vs 58.8% with propofol/lorazepam infusions) and shortens ICU/hospital length of stay 8
• Provides sedation with minimal respiratory depression 8
• Consider for patients requiring continuous sedation who are at high risk for respiratory failure

Clinical Algorithm for IV Medication Selection

Step 1: Assess Severity and Patient Factors

• CIWA-Ar score >8 = moderate AWS; ≥15 = severe AWS 2
• Evaluate for liver failure, respiratory compromise, advanced age, obesity

Step 2: Choose Initial IV Benzodiazepine

• Lorazepam 2-4 mg IV every 4-6 hours if: liver failure, elderly, respiratory disease, obesity, or uncertain hepatic function 1
• Diazepam 5-10 mg IV every 6-8 hours if: normal liver function, history of withdrawal seizures, younger patient 1

Step 3: Administer Thiamine FIRST

• 100-300 mg IV thiamine before any glucose-containing fluids 1

Step 4: Escalate if Refractory

• If inadequate response after 2-3 benzodiazepine doses or cumulative dose >40-60 mg lorazepam equivalents in 2-3 hours:
  • Add phenobarbital 10-20 mg/kg IV front-load 5, 4
  • Consider ICU transfer for closer monitoring
  • Evaluate for dexmedetomidine infusion if intubation risk is high 8

Step 5: Add Haloperidol Only for Specific Indications

• 2-5 mg IM haloperidol only if hallucinations or severe agitation persist despite adequate benzodiazepines 1

Critical Pitfalls to Avoid

1. Never give IV glucose before thiamine—this precipitates Wernicke encephalopathy 1
2. Do not use IM diazepam—erratic absorption makes it unreliable 9
3. Avoid benzodiazepines beyond 10-14 days—high abuse potential in this population 2
4. Do not rely solely on CIWA scores in patients with sepsis, hepatic encephalopathy, severe pain, or psychiatric comorbidities—these conditions artificially elevate scores 1
5. Phenobarbital requires expertise and protocols—use only within standardized, closely monitored hospital protocols 7, 3
6. Haloperidol is not primary treatment—it does not prevent seizures or delirium tremens 1

Monitoring Requirements

• Frequent vital signs (every 15-30 minutes initially) 1
• Assess for complications: dehydration, electrolyte imbalance, renal failure, head trauma, infection, GI bleeding, pancreatitis 1
• Watch for respiratory depression, especially with phenobarbital or high-dose benzodiazepines
• Evaluate need for ICU transfer if: delirium tremens, seizures, refractory symptoms, or respiratory compromise 1